We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Asthma Patient Survey Study to Assess Asthma Effect and Medication in Finland

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00681382
Recruitment Status : Completed
First Posted : May 21, 2008
Last Update Posted : January 24, 2011
Sponsor:
Information provided by:
AstraZeneca

May 19, 2008
May 21, 2008
January 24, 2011
October 2006
April 2007   (Final data collection date for primary outcome measure)
Patients perceptions about treatment of asthma, asthma medication and what are the most common triggers that cause exacerbations. [ Time Frame: Single occasion ]
Same as current
Complete list of historical versions of study NCT00681382 on ClinicalTrials.gov Archive Site
  • How patients react to the first signs of worsening of asthma i.e. how they use asthma medication during stable phase and asthma exacerbation [ Time Frame: Single occasion ]
  • How asthma affects everyday life [ Time Frame: Single occasion ]
Same as current
Not Provided
Not Provided
 
Asthma Patient Survey Study to Assess Asthma Effect and Medication in Finland
INSPIRE Asthma Patient Survey to Clarify the Use of Asthma Medication and Effects of Asthma in Everyday Life in Finland
This study was aimed at clarifying how the asthma medication is used in practice and how asthma affects everyday life. Total of 106 GPs were asked to recruit patients using inhaled steroid as maintenance treatment for asthma to take part in a telephone survey. Altogether 142 patients were interviewed.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Primary care clinic
Asthma
Not Provided
1
Asthma patients using inhaled steroids as maintenance treatment
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
142
April 2007
April 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosed persistent asthma
  • regular use of inhaled steroids and concomitant medication

Exclusion Criteria:

  • never been diagnosed COPD
  • seasonal asthma
Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00681382
NIS-RFI-SYM-2006/1
No
Not Provided
Not Provided
Klaus Tamminen - MC Medical Director, AstraZeneca
AstraZeneca
Not Provided
Study Director: Airi Puhakka AstraZeneca Finland
Principal Investigator: Jouni Hedman South Karelia Central Hospital, Finland
AstraZeneca
January 2011